Ai Weifu - About the company
Ai Weifu is a funded company based in Lanzhou (China), founded in 2017. It operates as a Provider of culture media and reagents for in vitro fertilization technique. The company has 126 active competitors, including 12 funded and 15 that have exited. Its top competitors include companies like ArcherDX, RNAConnect and Third Wave Technologies.
Company Details
Aivfo is a provider of culture media and reagents for the in vitro fertilization technique. The product catalog includes whole embryo culture medium, gamete buffer solution, vitrified liquid, vitrified thawing solution, and culture oil.
- Website
- aivfo.com
- Email ID
- *****@aivfo.com
- Phone Number
- +86 **********
Key Metrics
Founded Year
2017
Location
Lanzhou, China
Stage
Funding Raised
Investors
Ranked
115th among 126 active competitors
Sign up to download Ai Weifu's company profile
Ai Weifu's funding and investors
Ai Weifu is a funded company. Ai Weifu has 1 institutional investor.
View details of Ai Weifu's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ai Weifu's Competitors and alternates
Top competitors of Ai Weifu include ArcherDX, RNAConnect and Third Wave Technologies. Here is the list of Top 10 competitors of Ai Weifu, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ArcherDX 2013, Boulder (United States), Acquired | Developer of molecular cancer diagnostic products | $153M | 58/100 | |
2nd | RNAConnect 2023, Branford (United States), Funding Raised | Provider of reverse transcriptase solutions for RNA analysis | - | 48/100 | |
3rd | Third Wave Technologies 1993, Xiamen (China), Acquired | Molecular diagnostic test devices and reagents | $19.3M | 45/100 | |
4th | Nimagen 2011, Nijmegen (Netherlands), Unfunded | Developer of DNA sequencing reagents and kits | - | - | 43/100 |
5th | Diagnostic Hybrids 1983, Athens (United States), Acquired | Developer of molecular diagnostics kits for infectious diseases | $10M | 41/100 | |
6th | KogeneBiotech 2000, Seoul (South Korea), Unfunded | Manufacturer of molecular diagnostic products | - | - | 40/100 |
7th | CleanNA 2010, Waddinxveen (Netherlands), Seed | Manufacturer of DNA extraction kits and reagents | - | 40/100 | |
8th | Invivoscribe 1995, San Diego (United States), Unfunded | Provider of molecular diagnostics for personalized medicine in oncology | - | - | 40/100 |
9th | Developer of reagents and kits for molecular diagnostics | $1.56M | 40/100 | ||
10th | ThunderBio Innovation 2018, Jiaxing (China), Series B | Developer of microfluidic technology for diagnosis and research | $15.5M | 37/100 | |
115th | Provider of culture media and reagents for in vitro fertilization technique | - | 21/100 |
Looking for more details on Ai Weifu's competitors? Click here to see the top ones
Ai Weifu's Investments and acquisitions
Ai Weifu has made no investments or acquisitions yet.
Reports related to Ai Weifu
Here is the latest report on Ai Weifu's sector:
News related to Ai Weifu
•
Are you a Founder ?
FAQs about Ai Weifu
Explore our recently published companies
- Daileefoods - Thiruvananthapuram based, 2014 founded, Unfunded company
- Injury Case Funding - United States based, Unfunded company
- Saile Medical - New York City based, 2025 founded, Seed company
- Elm Biosciences - New York City based, 2024 founded, Seed company
- Whoranks - Wien based, 2024 founded, Funding Raised company
- Hedlum - New York City based, 2023 founded, Funding Raised company